Selective serotonin reuptake inhibitors and neuroendocrine function.

Area of Science:

• Neuroendocrinology
• Pharmacology
• Neuroscience

Background:

• Selective serotonin reuptake inhibitors (SSRIs) are crucial for treating neuropsychiatric disorders linked to reduced serotonergic function.
• Serotonergic neurons significantly influence neuroendocrine regulation.
• Understanding SSRI effects on neuroendocrine function is vital for optimizing treatment strategies.

Purpose of the Study:

• To review the acute and chronic effects of SSRIs on neuroendocrine function.
• To examine adaptive changes in neurotransmitter systems following long-term SSRI treatment.
• To elucidate the impact of SSRIs on hormone secretion and receptor sensitivity.

Main Methods:

• Review of existing literature on SSRI effects in experimental animals and humans.
• Analysis of neuroendocrine challenge tests assessing hormone responses (ACTH, cortisol, GH, prolactin, oxytocin, vasopressin).
• Examination of adaptive changes in serotonergic, noradrenergic, and peptidergic neural function.

Main Results:

• Acute SSRI administration elevates hormone secretion.
• Chronic SSRI treatment does not alter basal hormone levels but induces adaptive changes in neural function.
• SSRIs cause desensitization of 5-HT1A receptors and supersensitivity of 5-HT2A/2C receptors, altering hormone responses.

Conclusions:

• SSRI-induced neuroendocrine effects are primarily driven by adaptive changes in neurotransmitter systems.
• Long-term SSRI use modulates specific post-synaptic receptor systems, influencing hormone secretion.
• The neuroendocrine stress response and alpha2 adrenoceptor-mediated GH secretion remain largely unaffected by chronic SSRI exposure.